Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

AXIM Relative to the S&P 500

AXIM Relative to the Sector

Seasonal Chart Analysis

Analysis of the AXIM Biotechnologies Inc. (OTCMKT:AXIM) seasonal charts above shows that a Buy Date of March 13 and a Sell Date of July 2 has resulted in a geometric average return of 29.66% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 6 of those periods. This is a poor rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 65.12% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

AXIM Biotechnologies Inc is a vertically integrated research and development company focused on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells, as well as for oncological indications.

To download AXIM seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: AXIM